BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 16709241)

  • 1. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
    De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
    Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
    De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
    Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
    Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
    Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
    de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
    Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
    Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
    Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites.
    Longley DB; Allen WL; McDermott U; Wilson TR; Latif T; Boyer J; Lynch M; Johnston PG
    Clin Cancer Res; 2004 May; 10(10):3562-71. PubMed ID: 15161716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic and predictive profiling of 5-Fluorouracil resistance in human cancer cells.
    Wang W; Cassidy J; O'Brien V; Ryan KM; Collie-Duguid E
    Cancer Res; 2004 Nov; 64(22):8167-76. PubMed ID: 15548681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle perturbation and acquired 5-fluorouracil chemoresistance.
    Guo X; Goessl E; Jin G; Collie-Duguid ES; Cassidy J; Wang W; O'Brien V
    Anticancer Res; 2008; 28(1A):9-14. PubMed ID: 18383818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
    Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
    Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.
    Maxwell PJ; Longley DB; Latif T; Boyer J; Allen W; Lynch M; McDermott U; Harkin DP; Allegra CJ; Johnston PG
    Cancer Res; 2003 Aug; 63(15):4602-6. PubMed ID: 12907638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray.
    Park JS; Young Yoon S; Kim JM; Yeom YI; Kim YS; Kim NS
    Cancer Lett; 2004 Oct; 214(1):19-33. PubMed ID: 15331170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
    Petak I; Tillman DM; Houghton JA
    Clin Cancer Res; 2000 Nov; 6(11):4432-41. PubMed ID: 11106264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
    Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
    Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
    McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
    Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells.
    Ju J; Schmitz JC; Song B; Kudo K; Chu E
    Clin Cancer Res; 2007 Jul; 13(14):4245-51. PubMed ID: 17634554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2.
    Jordan A; Stein J
    Eur J Nutr; 2003 Dec; 42(6):324-31. PubMed ID: 14673605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.
    Mariadason JM; Arango D; Shi Q; Wilson AJ; Corner GA; Nicholas C; Aranes MJ; Lesser M; Schwartz EL; Augenlicht LH
    Cancer Res; 2003 Dec; 63(24):8791-812. PubMed ID: 14695196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status.
    Adamsen BL; Kravik KL; De Angelis PM
    Int J Oncol; 2011 Sep; 39(3):673-82. PubMed ID: 21674128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.